日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer.

局部应用 TLR7 激动剂和放射疗法治疗转移性乳腺癌患者

Adams Sylvia, Demaria Sandra, Rinchai Darawan, Wang Ena, Novik Yelena, Oratz Ruth, Fenton-Kerimian Maria, Levine Pascale G, Li Xiaochun, Marincola Francesco, Jin Ping, Stroncek David, Goldberg Judith, Bedognetti Davide, Formenti Silvia Chiara

Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study

评估新诊断为激素受体阳性乳腺癌的绝经后女性与健康女性的肠道微生物群和性激素水平:一项前瞻性病例对照研究

Kwa, Maryann; Hussey, Grant; Novik, Yelena; Franke, Adrian A; Volkova, Angelina; Flores, Karina; Blaser, Martin J; Speyer, James; Oratz, Ruth; Meyers, Marleen; Jhaveri, Komal; Fadel, Ezeddin; Heguy, Adriana; Schluter, Jonas; Ruggles, Kelly V; Adams, Sylvia

Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic

COVID-19 大流行期间接受化疗、生物疗法、内分泌疗法或积极监测的乳腺癌患者的治疗结果

Marks, Douglas K; Budhathoki, Nibash; Kucharczyk, John; Fa'ak, Faisal; D'Abreo, Nina; Kwa, Maryann; Plasilova, Magdalena; Dhage, Shubhada; Soe, Phyu Phyu; Becker, Daniel; Hindenburg, Alexander; Lee, Johanna; Winner, Megan; Okpara, Chinyere; Daly, Alison; Shah, Darshi; Ramdhanny, Angela; Meyers, Marleen; Oratz, Ruth; Speyer, James; Novik, Yelena; Schnabel, Freya; Jones, Simon A; Adams, Sylvia

Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer

一项针对三阴性乳腺癌的辅助同步卡铂化疗和加速放疗的I/II期研究结果

Formenti, Silvia C; Golden, Encouse B; Goldberg, Judith D; Li, Xiaochun; Taff, Jessica; Fenton-Kerimian, Maria B; Chandrasekhar, Sharanya; Demaria, Sandra; Novik, Yelena

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial

一项随机II期临床试验,评估氟维司群单药或联合硼替佐米治疗对芳香化酶抑制剂耐药的激素受体阳性转移性乳腺癌的疗效:纽约癌症联盟试验

Adelson, Kerin; Ramaswamy, Bhuvaneswari; Sparano, Joseph A; Christos, Paul J; Wright, John J; Raptis, George; Han, Gang; Villalona-Calero, Miguel; Ma, Cynthia X; Hershman, Dawn; Baar, Joseph; Klein, Paula; Cigler, Tessa; Budd, G Thomas; Novik, Yelena; Tan, Antoinette R; Tannenbaum, Susan; Goel, Anupama; Levine, Ellis; Shapiro, Charles L; Andreopoulou, Eleni; Naughton, Michael; Kalinsky, Kevin; Waxman, Sam; Germain, Doris

Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer

脂质体阿霉素联合多西他赛治疗转移性乳腺癌患者的II期临床试验

Fasano, Julie; Hershman, Dawn; Novik, Yelena; Levinson, Benjamin; Blozie, Kim; Tiersten, Amy D